Dan Gibson

12.4k total citations · 1 hit paper
144 papers, 10.3k citations indexed

About

Dan Gibson is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Dan Gibson has authored 144 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 85 papers in Organic Chemistry and 41 papers in Molecular Biology. Recurrent topics in Dan Gibson's work include Metal complexes synthesis and properties (98 papers), Ferrocene Chemistry and Applications (49 papers) and DNA and Nucleic Acid Chemistry (21 papers). Dan Gibson is often cited by papers focused on Metal complexes synthesis and properties (98 papers), Ferrocene Chemistry and Applications (49 papers) and DNA and Nucleic Acid Chemistry (21 papers). Dan Gibson collaborates with scholars based in Israel, Czechia and United States. Dan Gibson's co-authors include Raphael Mechoulam, Graeme Griffin, Lesley Stevenson, Roger G. Pertwee, Asher Mandelbaum, Aviva Breuer, William A. Devane, Ezequiel Wexselblatt, Yousef Najajreh and Viktor Brabec and has published in prestigious journals such as Science, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Dan Gibson

141 papers receiving 10.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

1992 4.5k citations Dan Gibson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Dan Gibson	4.2k	3.9k	2.8k	2.6k	2.1k	144	10.3k
Kevin J. Barnham	2.3k 0.6×	2.7k 0.7×	1.3k 0.5×	7.0k 2.7×	1.5k 0.7×	221	18.3k
Carla Ghelardini	2.1k 0.5×	1.2k 0.3×	2.5k 0.9×	6.0k 2.4×	2.7k 1.2×	525	13.8k
Victor W. Pike	1.8k 0.4×	1.9k 0.5×	1.9k 0.7×	4.6k 1.8×	4.4k 2.1×	433	15.4k
Charles R. Ashby	970 0.2×	2.4k 0.6×	679 0.2×	5.3k 2.1×	3.8k 1.8×	246	10.9k
Alan Davison	1.5k 0.4×	1.8k 0.5×	3.2k 1.1×	3.9k 1.5×	2.4k 1.1×	359	14.7k
Alan P. Kozikowski	2.8k 0.7×	3.1k 0.8×	9.1k 3.3×	12.4k 4.8×	3.0k 1.4×	567	23.3k
Lorenzo Di Cesare Mannelli	1.3k 0.3×	1.1k 0.3×	1.6k 0.6×	3.7k 1.5×	902 0.4×	314	8.7k
Hank F. Kung	1.2k 0.3×	867 0.2×	1.0k 0.4×	3.7k 1.5×	4.0k 1.9×	290	13.1k
Robert A. Cherny	2.0k 0.5×	1.2k 0.3×	340 0.1×	4.3k 1.7×	1.6k 0.8×	96	13.5k
Enrico Rizzarelli	608 0.1×	1.6k 0.4×	2.0k 0.7×	4.0k 1.6×	837 0.4×	305	10.7k

Countries citing papers authored by Dan Gibson

Since Specialization

Citations

This map shows the geographic impact of Dan Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Gibson more than expected).

Fields of papers citing papers by Dan Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Gibson. The network helps show where Dan Gibson may publish in the future.

Co-authorship network of co-authors of Dan Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Gibson. A scholar is included among the top collaborators of Dan Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Gibson. Dan Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Xinyi, Wei Heng Chng, Kevin Tay, et al.. (2025). Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. Chemical Reviews. 125(21). 10248–10341. 1 indexed citations

2.

Kostrhunová, Hana, et al.. (2025). Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models. Journal of Medicinal Chemistry. 68(22). 24094–24107.

3.

Oliveira, Luís, et al.. (2025). A Triple Threat Against Ovarian Cancer: Os(II)‐Pt(IV)‐Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction. Angewandte Chemie International Edition. 64(49). e202518623–e202518623.

4.

Sarkar, Amrita, Vojtěch Novohradský, Lenka Marková, et al.. (2023). Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death. Angewandte Chemie International Edition. 62(42). e202310774–e202310774. 33 indexed citations

5.

Berger, Walter, et al.. (2023). Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugs. Inorganic Chemistry Frontiers. 11(2). 534–548. 10 indexed citations

6.

Basu, Uttara, Hemma Schueffl, Sarah Theiner, et al.. (2023). Oral Anticancer Heterobimetallic Pt^IV−Au^IComplexes Show High In Vivo Activity and Low Toxicity. Angewandte Chemie. 135(10). 4 indexed citations

7.

Lachowicz, Joanna Izabela, Anna Mateddu, Pierpaolo Coni, et al.. (2022). Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(iii) and aluminium(iii) kojic acid derivative complexes. Dalton Transactions. 51(16). 6254–6263. 2 indexed citations

8.

Babak, Maria V., Zhi Yang, Bertrand Czarny, et al.. (2019). Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity. Angewandte Chemie International Edition. 58(24). 8109–8114. 95 indexed citations

9.

Babak, Maria V., Zhi Yang, Bertrand Czarny, et al.. (2019). Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity. Angewandte Chemie. 131(24). 8193–8198. 27 indexed citations

10.

Novohradský, Vojtěch, Ilaria Zanellato, Cristina Marzano, et al.. (2017). Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates. Scientific Reports. 7(1). 3751–3751. 35 indexed citations

11.

Tallafuß, Alexandra, Meghan Kelly, Leslie Gay, et al.. (2015). Transcriptomes of post-mitotic neurons identify the usage of alternative pathways during adult and embryonic neuronal differentiation. BMC Genomics. 16(1). 1100–1100. 12 indexed citations

12.

Aizenman, Einat, et al.. (2014). Zygote serine decreased uptake from the fertilization medium is associated with implantation and pregnancy. Journal of Assisted Reproduction and Genetics. 31(7). 889–897. 8 indexed citations

13.

Wexselblatt, Ezequiel, Eylon Yavin, & Dan Gibson. (2013). Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions. Angewandte Chemie International Edition. 52(23). 6059–6062. 78 indexed citations

14.

Wexselblatt, Ezequiel & Dan Gibson. (2012). What do we know about the reduction of Pt(IV) pro-drugs?. Journal of Inorganic Biochemistry. 117. 220–229. 311 indexed citations

15.

Gibson, Dan. (2009). The mechanism of action of platinum anticancer agents—what do we really know about it?. Dalton Transactions. 10681–10681. 161 indexed citations

16.

Stürup, Stefan, et al.. (2008). Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts. JBIC Journal of Biological Inorganic Chemistry. 14(3). 387–399. 27 indexed citations

17.

Kašpárková, Jana, Olga Nováková, Victoria Marini, et al.. (2003). Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand. Journal of Biological Chemistry. 278(48). 47516–47525. 57 indexed citations

18.

Peleg‐Shulman, Tal, et al.. (2001). Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1510(1-2). 278–291. 67 indexed citations

19.

Gibson, Dan, et al.. (1991). Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalators. Journal of Medicinal Chemistry. 34(1). 414–420. 57 indexed citations

20.

Ringel, Israel, et al.. (1988). N-Alkyl colchiceineamides: their inhibition of GTP or taxol-induced assembly of tubulin. Biochemical Pharmacology. 37(12). 2487–2489. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact